MARKET

AXGN

AXGN

Axogen Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.33
-0.38
-3.91%
After Hours: 9.33 0 0.00% 16:09 03/27 EDT
OPEN
9.51
PREV CLOSE
9.71
HIGH
10.16
LOW
9.23
VOLUME
434.32K
TURNOVER
--
52 WEEK HIGH
25.84
52 WEEK LOW
7.76
MARKET CAP
370.69M
P/E (TTM)
-12.5538
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AXGN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AXGN stock price target is 22.17 with a high estimate of 30.00 and a low estimate of 19.00.

EPS

AXGN News

More
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37
  • The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
  • Benzinga · 03/11 12:05
  • Edited Transcript of AXGN earnings conference call or presentation 24-Feb-20 9:30pm GMT
  • Thomson Reuters StreetEvents · 03/06 12:05
  • Axogen, Inc. to Participate at Upcoming Investor Conferences
  • GlobeNewswire · 03/02 12:00

Industry

Advanced Medical Equipment & Technology
-2.20%
Healthcare Equipment & Supplies
-1.86%

Hot Stocks

Symbol
Price
%Change

About AXGN

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.
More

Webull offers kinds of Axogen Inc. stock information, including NASDAQ:AXGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXGN stock news, and many more online research tools to help you make informed decisions.